CBA in first US dollar-based bond issue

By Tim Neary | 17/03/2010 12:00:00 AM | 0 comments

Having already posted record results for the six months to December 2009, the CBA has made its intentions known for much of the same in the year ahead by raising $US3.5 billion ($3.82 billion) in the first US dollar-denominated bond issue this year.

According to a report in The Australian Financial Review the deal was split into three tranches with maturities stretching between three and 10 years.

Citigroup, Goldman Sachs and HSBC managed the bond issue. 

As a stand-alone business the CBA reported a staggering 54% jump in interim profit at the end of last year, recording cash NPAT of $2.94bn. 

The jump was attributed to the bank increasing its market share and "significant growth in outstanding home loan balances".

Brokers received a mention when the results were announced last month, with the bank saying balance growth was "supported by competitive standard variable home loan rates...and a strong branch and broker presence, with both channels continuing to outperform market growth".

Related Story 

CBA, ANZ, St.George match RBA increase - The Commonwealth Bank, ANZ and St.George have matched the RBA's 25bps increase announced yesterday with Westpac and NAB expected to do the same.

  

Bookmark and Share ALB

Latest Comments

E-Newsletter

enews
Our daily newsletter is FREE and keeps you up-to-date with the world of lenders, aggregators, brokers and loans.
Subscribe Today

AB issue 8.24

E-Mag

AB issue 8.24 OUT NOW
Home lenders next as brokers found wanting; NAB Broker scores with ‘disparity’ r ...

view online

E-Mag Get Updated

enews
Australian Broker's e-mag provides all of the in-depth news, opinion and analysis available in our print edition straight to your inbox
Subscribe Today

Your comment

Broker news forum is the place for positive industry interaction and welcomes your professional and informed opinion.
Name

Comment


By submitting, I agree to the Terms & Conditions

You are about to submit your comment. Please ensure it is:

  • Professional
  • In your own name or pseudonym, not impersonating someone else
  • Free from offensive language
  • Free from advertising
  • Please also see our Terms & Conditions

If you prefer not to post but want to get your viewpoint across, you can always email the editor.